Literature DB >> 10976046

X-chromosome inactivation in XX androgenetic mouse embryos surviving implantation.

I Okamoto1, S Tan, N Takagi.   

Abstract

Using genetic and cytogenetic markers, we assessed early development and X-chromosome inactivation (X-inactivation) in XX mouse androgenones produced by pronuclear transfer. Contrary to the current view, XX androgenones are capable of surviving to embryonic day 7.5, achieving basically random X-inactivation in all tissues including those derived from the trophectoderm and primitive endoderm that are characterized by paternal X-activation in fertilized embryos. This finding supports the hypothesis that in fertilized female embryos, the maternal X chromosome remains active until the blastocyst stage because of a rigid imprint that prevents inactivation, whereas the paternal X chromosome is preferentially inactivated in extra-embryonic tissues owing to lack of such imprint. In spite of random X-inactivation in XX androgenones, FISH analyses revealed expression of stable Xist RNA from every X chromosome in XX and XY androgenonetic embryos from the four-cell to morula stage. Although the occurrence of inappropriate X-inactivation was further suggested by the finding that Xist continues ectopic expression in a proportion of cells from XX and XY androgenones at the blastocyst and the early egg cylinder stage, a replication banding study failed to provide positive evidence for inappropriate X-inactivation at E6. 5.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10976046     DOI: 10.1242/dev.127.19.4137

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  20 in total

Review 1.  Epigenesis and plasticity of mouse trophoblast stem cells.

Authors:  Julie Prudhomme; Céline Morey
Journal:  Cell Mol Life Sci       Date:  2015-11-05       Impact factor: 9.261

2.  Initiation of epigenetic reprogramming of the X chromosome in somatic nuclei transplanted to a mouse oocyte.

Authors:  Siqin Bao; Naoki Miyoshi; Ikuhiro Okamoto; Thomas Jenuwein; Edith Heard; M Azim Surani
Journal:  EMBO Rep       Date:  2005-08       Impact factor: 8.807

3.  Differential methylation of Xite and CTCF sites in Tsix mirrors the pattern of X-inactivation choice in mice.

Authors:  Rebecca Maxfield Boumil; Yuya Ogawa; Bryan K Sun; Khanh D Huynh; Jeannie T Lee
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

4.  Understanding the X chromosome inactivation cycle in mice: a comprehensive view provided by nuclear transfer.

Authors:  Mami Oikawa; Kimiko Inoue; Hirosuke Shiura; Shogo Matoba; Satoshi Kamimura; Michiko Hirose; Kazuyuki Mekada; Atsushi Yoshiki; Satoshi Tanaka; Kuniya Abe; Fumitoshi Ishino; Atsuo Ogura
Journal:  Epigenetics       Date:  2013-10-29       Impact factor: 4.528

Review 5.  Regulation of X-chromosome inactivation by the X-inactivation centre.

Authors:  Sandrine Augui; Elphège P Nora; Edith Heard
Journal:  Nat Rev Genet       Date:  2011-06       Impact factor: 53.242

6.  An ex vivo model for imprinting: mutually exclusive binding of Cdx2 and Oct4 as a switch for imprinted and random X-inactivation.

Authors:  Jennifer A Erwin; Brian del Rosario; Bernhard Payer; Jeannie T Lee
Journal:  Genetics       Date:  2012-08-31       Impact factor: 4.562

Review 7.  Recent advances in X-chromosome inactivation.

Authors:  Sundeep Kalantry
Journal:  J Cell Physiol       Date:  2011-07       Impact factor: 6.384

8.  X-inactivation and X-reactivation: epigenetic hallmarks of mammalian reproduction and pluripotent stem cells.

Authors:  Bernhard Payer; Jeannie T Lee; Satoshi H Namekawa
Journal:  Hum Genet       Date:  2011-06-12       Impact factor: 4.132

Review 9.  Maternal H3K27me3-dependent autosomal and X chromosome imprinting.

Authors:  Zhiyuan Chen; Yi Zhang
Journal:  Nat Rev Genet       Date:  2020-06-08       Impact factor: 53.242

Review 10.  Genomic imprinting mechanisms in mammals.

Authors:  Folami Y Ideraabdullah; Sebastien Vigneau; Marisa S Bartolomei
Journal:  Mutat Res       Date:  2008-08-20       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.